This initial demonstration of CHIP mutations in local tissues of patients with PAD suggested that CHIP may play a role in PAD pathophysiology and that anti-inflammatory therapies targeting CHIP may be useful in treating PAD [84]. The gene discussed is STUB1; the disease is peripheral arterial disease.